07 Dec BioSpectrum Asia recognises achievements at Excellence Awards 2024 in Singapore
Witnessing the convergence of brilliance as we recognise the industry’s finest at BioSpectrum Asia Excellence awards 2024 night
To recognise and celebrate the remarkable achievements and contributions of Asian companies and individuals in the life sciences sector, BioSpectrum Asia organised the Excellence Awards 2024 in Singapore on 6th December.
This prestigious event honoured the outstanding performers of the calendar year 2023 & 2024, underscoring Asia’s emergence as a global hub for innovation and growth in the life sciences industry.
The BioSpectrum Asia Excellence Awards 2024 comprised of two segments- Jury Special and Industry Special Awards.
Winners for our Industry Special segment included-
Top Company for Bioprocessing – Eppendorf
Top Company in Manufacturing Technology & Equipment – Cytiva
Top Company in Packaging & Drug Delivery Services – West Pharma
Top Company in Supply Chain Logistics & Distribution – Catalent Pharma Solutions
Top Company in Clinical Research-Based Development – Medidata
Top Innovation & Collaborations in ADC Drug Development – GenScript Biotech
Innovative Biotech Solutions – Ardor Biomed India
Emerging Al Powered Drug Discovery Platform – Molecule AI
Top Company in Medical Packaging – Oliver Healthcare Packaging
Outstanding Leadership in MedTech Advocacy in Asia-Pacific Award- Special Recognition – APACMed
Excellence in medtech innovation- Medtronic
Winners of the Jury Special category included-
Entrepreneur of the year- Dr Jogin Desai from Eyestem Research & Dr Lynne Lim for NousQ
Emerging startup of the year- ImmunoAct, and Aevice Health
Businessperson of the year– Dr Christian Behrenbruch, Managing Director and Group CEO of Telix Pharmaceuticals
Product of the year– Needle free injection system technology by IntegriMedical
In conjunction with the prestigious BioSpectrum Asia Excellence Awards 2024, a panel discussion was organised on the critical topic: “Biomanufacturing: Advancing Towards a Sustainable Bioeconomy in Asia.” powered by Cytiva.
The discussion was moderated by Dr Satya Dash– President Strategy Bigtec, Founding Head Strategy, BIRAC, Government of India; while the speakers included Damian Cher, Director of Manufacturing Capacity Solution in Asia Pacific, Cytiva; Franco So, Head of Bioprocess, Sales, Asia Pacific China, Eppendorf; Lew Fei-Chuin, Biopharma Market Manager, Agilent Technologies; Dr. Saket Jhajharia, Chief Operating Officer, ID Capital; and Dr Dario Heymann, Chief Research Officer, Galen Growth Singapore & AI Office, SingHealth.
BioSpectrum Asia is proud to play a critical role of picking tomorrow’s winners, nudging today’s entrepreneurs to achieve greater glory and honouring yesterday’s key players who laid the foundation for success.